Fig 1.
Flow chart of studies considered for inclusion.
Table 1.
Nodule characteristics in the included studies.
Table 2.
Results of pooled outcomes in the network meta-analysis and pairwise meta-analysis.
Fig 2.
Evidence structure of eligible comparisons.
(A)Network diagrams of comparisons for the percentage mean change in benign thyroid nodule volume during 6-month follow-up after thermal/chemical ablation. (B) Network diagrams of comparisons for the percentage mean change in solid or predominantly solid benign thyroid nodule volume after thermal/chemical ablation. (C) Network diagrams of comparisons for the percentage mean change in cyst or predominantly cyst benign thyroid nodule volume after thermal/chemical ablation. RFA: Radiofrequency Ablation with single treatment session; RFA2: Radiofrequency Ablation with 2 treatment session; EA: ethanol ablation with single treatment session; EA3: ethanol ablation with 3 treatment session; LA: Laser Ablation with single treatment session; LA3: Laser Ablation with 3 treatment session. HIFU: High-Intensity Focused Ultrasound.
Table 3.
Results of network meta-analysis for percentage mean volume change of benign thyroid nodules after percutaneous ablation therapies in 6- and 12-month follow-up and symptom score and cosmetic score change of benign thyroid nodules after percutaneous ablation therapies in 6 months.
Table 4.
Results of network meta-analysis for percent mean volume change in the subgroup of solid or cyst benign thyroid nodules after percutaneous ablation therapies.
Table 5.
SUCRA values and ranks of percentage mean volume changes, symptom score and cosmetic score.